Guggenheim has initiated its coverage of psychedelic drug developer Cybin (NYSE:CYBN ... wrote as he projected further upside for the stock given a mid-stage readout expected for CYBN’s anxiety ...

On Thursday, H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the ...

Explore Cybin stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CYBN. Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression Cybin ...

On Wednesday, Canaccord Genuity revised its price target for Cybin Inc. (NYSE:CYBN) shares, reducing it to $73.00 from the previous $86.00, while continuing to endorse the stock with a Buy rating.